{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:17:16Z","timestamp":1778671036903,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s11095-012-0853-y","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T20:27:15Z","timestamp":1345494435000},"page":"104-116","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of Metal-Chelating Polymers (MCPs) for 111In Complexed via the Streptavidin-Biotin System to Trastuzumab Fab Fragments on Tumor and Normal Tissue Distribution in Mice"],"prefix":"10.1007","volume":"30","author":[{"given":"Amanda J.","family":"Boyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Weinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Scollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislaine","family":"Ngo Njock Mbong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell A.","family":"Winnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"853_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00003495-200262010-00008","volume":"62","author":"K McKeage","year":"2002","unstructured":"McKeage K, Perry CM. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2. Drugs. 2002;62:209\u201343.","journal-title":"Drugs"},{"key":"853_CR2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2967\/jnumed.106.037937","volume":"48","author":"DL Costantini","year":"2007","unstructured":"Costantini DL, Chan C, Cai Z, Vallis KA, Reilly RM. 111In-labeled trastuzumab (Herceptin) modified with nuclear localizing sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2\/neu-amplified breast cancer. J Nucl Med. 2007;48:1357\u201368.","journal-title":"J Nucl Med"},{"key":"853_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cbr.2007.0430","volume":"23","author":"DL Costantini","year":"2008","unstructured":"Costantini DL, Hu M, Reilly RM. Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications. Cancer Biother Radiopharm. 2008;23:3\u201324.","journal-title":"Cancer Biother Radiopharm"},{"key":"853_CR4","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2967\/jnumed.108.051771","volume":"49","author":"DL Costantini","year":"2008","unstructured":"Costantini DL, Bateman K, McLarty K, Vallis KA, Reilly RM. Trastuzumab-resistant breast cancer cells remain sensitive to the Auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate. J Nucl Med. 2008;49:1498\u2013505.","journal-title":"J Nucl Med"},{"key":"853_CR5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bc9800567","volume":"10","author":"VP Torchilin","year":"1999","unstructured":"Torchilin VP. Biotin-conjugated polychelating agent. Bioconjug Chem. 1999;10:146\u20139.","journal-title":"Bioconjug Chem"},{"key":"853_CR6","doi-asserted-by":"crossref","unstructured":"Liu P, Boyle AJ, Lu Y, Reilly RM, Winnik M. Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment. Biomacromolecules 2012. doi: 10.1021\/bm300843u .","DOI":"10.1021\/bm300843u"},{"key":"853_CR7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/bm2018239","volume":"13","author":"Y Lu","year":"2012","unstructured":"Lu Y, Chau M, Boyle AJ, Liu P, Niehoff A, Weinrich D, et al. Effect of pendant group structure on the hydrolytic stability of polyaspartamide polymers under physiological conditions. Biomacromolecules. 2012;13:1296\u2013306.","journal-title":"Biomacromolecules"},{"key":"853_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2191-219X-1-11","volume":"1","author":"C Chan","year":"2011","unstructured":"Chan C, Scollard DA, McLarty K, Smith S, Reilly RM. A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT\/CT or microPET\/CT. EJNMMI Res. 2011;1:11.","journal-title":"EJNMMI Res"},{"key":"853_CR9","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1016\/S0040-4039(00)97976-0","volume":"31","author":"M Green","year":"1990","unstructured":"Green M, Berman J. Preparation of pentafluorophenyl esters of FMOC protected amino acids with pentafluorophenyl trifluoroacetate. Tetrahedron Letters. 1990;31:5851\u20132.","journal-title":"Tetrahedron Letters"},{"key":"853_CR10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1039\/c39920001296","volume":"18","author":"DH Grayson","year":"1992","unstructured":"Grayson DH, Roycroft ED. Synthesis of butanolides via intramolecular acylative ring-opening reactions of 3-(tetrahydro-2-furyl)propanoic acid derivatives. J Chem Soc Chem Commun. 1992;18:1296\u20137.","journal-title":"J Chem Soc Chem Commun"},{"key":"853_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nucmedbio.2004.08.003","volume":"32","author":"Y Tang","year":"2005","unstructured":"Tang Y, Wang J, Scollard DA, Mondal H, Holloway C, Kahn HJ, et al. Imaging of HER2\/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments. Nucl Med Biol. 2005;32:51\u20138.","journal-title":"Nucl Med Biol"},{"key":"853_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.nucmedbio.2010.06.010","volume":"38","author":"DA Scollard","year":"2011","unstructured":"Scollard DA, Chan C, Holloway CMB, Reilly RM. A kit to prepare 111In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER-2 positive breast cancer. Nucl Med Biol. 2011;38:129\u201336.","journal-title":"Nucl Med Biol"},{"key":"853_CR13","first-page":"1023","volume":"47","author":"RM Reilly","year":"2006","unstructured":"Reilly RM, Chen P, Wang J, Scollard D, Cameron R, Vallis KA. Preclinical pharmacokinetic, biodistribution, toxicology and dosimry studies of 111In-DTPA-hEGF - an Auger electron-emitting radiotherapeutic agent for EGFR-positive breast cancer. J Nucl Med. 2006;47:1023\u201331.","journal-title":"J Nucl Med"},{"key":"853_CR14","doi-asserted-by":"crossref","unstructured":"Majonis D, Ornatsky O, Kinach R, Winnik MA. Curious results with palladium- and platinum-carrying polymers in mass cytometry bioassays and an unexpected application as a dead cell stain. Biomacromolecules. 2011;12:3997\u20134010.","DOI":"10.1021\/bm201011t"},{"key":"853_CR15","first-page":"406","volume":"6","author":"SJ Knox","year":"2000","unstructured":"Knox SJ, Goris ML, Tempero M, Weiden PL, Gentner L, Breitz H, et al. Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody\/streptavidin in patients with metastatic colon cancer. Clin Cancer Res. 2000;6:406\u201314.","journal-title":"Clin Cancer Res"},{"key":"853_CR16","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1073\/pnas.83.8.2632","volume":"83","author":"JD Rodwell","year":"1986","unstructured":"Rodwell JD, Alvarez VL, Lee C, Lopes AD, Goers JWF, King HD, et al. Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluation. Proc Natl Acad Sci USA. 1986;83:2632\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"853_CR17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mrm.1910080208","volume":"8","author":"AD Sherry","year":"1988","unstructured":"Sherry AD, Cacheris WP, Kuan KT. Stability constants for Gd3+ binding to model DTPA-conjugates and DTPA-proteins: implications for their use as magnetic resonance contrast agents. Magn Reson Med. 1988;8:180\u201390.","journal-title":"Magn Reson Med"},{"key":"853_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00006231-200605000-00008","volume":"27","author":"JE Hainsworth","year":"2006","unstructured":"Hainsworth JE, Harrison P, Mather SJ. Novel preparation and characterization of a trastuzumab-streptavidin conjugate for pre-targeted radionuclide therapy. Nucl Med Commun. 2006;27:461\u201371.","journal-title":"Nucl Med Commun"},{"key":"853_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/bm201479t","volume":"13","author":"B Hoang","year":"2012","unstructured":"Hoang B, Reilly RM, Allen C. Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells. Biomacromolecules. 2012;13:455\u201365.","journal-title":"Biomacromolecules"},{"key":"853_CR20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/mp100105c","volume":"7","author":"T Miyano","year":"2010","unstructured":"Miyano T, Wijagkanalan W, Kawakami S, Yamashita F, Hashida M. Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells. Mol Pharmaceut. 2010;7:1318\u201327.","journal-title":"Mol Pharmaceut"},{"key":"853_CR21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/bc050348p","volume":"17","author":"R Shukla","year":"2006","unstructured":"Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, et al. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjug Chem. 2006;17:1109\u201315.","journal-title":"Bioconjug Chem"},{"key":"853_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-199528020-00004","volume":"28","author":"RM Reilly","year":"1995","unstructured":"Reilly RM, Sandhu J, Alvarez-Diez TM, Gallinger S, Kirsh J, Stern H. Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet. 1995;28:126\u201342.","journal-title":"Clin Pharmacokinet"},{"key":"853_CR23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","volume":"55","author":"P Caliceti","year":"2003","unstructured":"Caliceti P, Veronese FM. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev. 2003;55:1261\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"853_CR24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0969-8051(93)90075-6","volume":"20","author":"MA Slinkin","year":"1993","unstructured":"Slinkin MA, Curtet C, Faivre-Chauvet A, Sai-Maurel C, Gestin JF, Torchilin VP, et al. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. Nucl Med Biol. 1993;20:443\u201352.","journal-title":"Nucl Med Biol"},{"key":"853_CR25","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.biomaterials.2011.01.021","volume":"32","author":"K Xiao","year":"2011","unstructured":"Xiao K, Li Y, Luo J, Lee JS, Xiao W, Gonik AM, et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 2011;32:3435\u201346.","journal-title":"Biomaterials"},{"key":"853_CR26","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1016\/j.biomaterials.2009.11.072","volume":"31","author":"K Itaka","year":"2010","unstructured":"Itaka K, Ishii T, Hasegawa Y, Kataoka K. Biodegradable polyamino acid-based polycations as safe and effective gene carrier minimizing cumulative toxicity. Biomaterials. 2010;31:3707\u201314.","journal-title":"Biomaterials"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-012-0853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-012-0853-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-012-0853-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:26Z","timestamp":1559368466000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-012-0853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1007\/s11095-012-0853-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,21]]}}}